Understanding the precise role of LNMAT1 in the LN metastasis of bladder cancer and in activation of the CCL2/TAMs axis will not only increase our knowledge of lncRNA-induced LN metastasis but also enable the development of a therapeutic strategy for bladder cancer LN metastasis. This evidence concerns the gene DUXAP9 and urinary bladder cancer.